The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells

Author： Yoshida D.   Koketshu K   Nomura R.   Teramoto A.  

Publisher： Springer Publishing Company

ISSN： 0167-594X

Source： Journal of Neuro-Oncology, Vol.100, Iss.1, 2010-10, pp. : 51-64

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent

By Cashen Amanda F   Nervi Bruno   DiPersio John  

Future Oncology, Vol. 3, Iss. 1, 2007-02 ,pp. : 19-27

Future Medicine

Access to resources Recommend Favorite

AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments

By                  

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 33-42

Spandidos Publications

Access to resources Recommend Favorite

Ursolic acid suppresses growth and adrenocorticotrophic hormone secretion in AtT20 cells as a potential agent targeting adrenocorticotrophic hormoneproducing pituitary adenoma

By            

Molecular Medicine Reports, Vol. 9, Iss. 6, 2014-01 ,pp. : 2533-2539

Spandidos Publications

Access to resources Recommend Favorite

Hypoxia-mediated immune evasion of pancreatic carcinoma cells

By          

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3666-3672

Spandidos Publications

Access to resources Recommend Favorite

Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cells

By Yang Bo   Fan Lingling   Fang Liang   He Qiaojun  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 4, 2006-10 ,pp. : 540-546

Springer Publishing Company

Access to resources Recommend Favorite